Experimental studies suggest that MPN remodels the endosteal BM niche into a self-reinforcing leukemic niche through thrombopoietin, chemokine ligand 3 (CCL3), and direct cell-cell interactions (16). This evidence concerns the gene CCL3 and myeloproliferative disorder.